Valencia B, Sigera P, Weeratunga P, Tedla N, Fernando D, Rajapakse S
Sci Rep. 2022; 12(1):17225.
PMID: 36241869
PMC: 9568574.
DOI: 10.1038/s41598-022-22231-y.
Hou J, Ye W, Chen J
Front Immunol. 2022; 13:840104.
PMID: 35281026
PMC: 8907379.
DOI: 10.3389/fimmu.2022.840104.
Kularatne S, Dalugama C
Clin Med (Lond). 2022; 22(1):9-13.
PMID: 35078789
PMC: 8813012.
DOI: 10.7861/clinmed.2021-0791.
Huang S, Tsai H, Hung S, Ko W, Wang J
PLoS Negl Trop Dis. 2020; 14(12):e0008960.
PMID: 33362244
PMC: 7757819.
DOI: 10.1371/journal.pntd.0008960.
Chokephaibulkit K, Chien Y, AbuBakar S, Pattanapanyasat K, Perng G
Viruses. 2020; 12(11).
PMID: 33167518
PMC: 7694450.
DOI: 10.3390/v12111261.
Sequential immunization induces strong and broad immunity against all four dengue virus serotypes.
Hou J, Shrivastava S, Loo H, Wong L, Ooi E, Chen J
NPJ Vaccines. 2020; 5(1):68.
PMID: 32728482
PMC: 7382454.
DOI: 10.1038/s41541-020-00216-0.
Validation of a Novel Zebrafish Model of Dengue Virus (DENV-3) Pathology Using the Pentaherbal Medicine Denguenil Vati.
Balkrishna A, Solleti S, Verma S, Varshney A
Biomolecules. 2020; 10(7).
PMID: 32605167
PMC: 7408079.
DOI: 10.3390/biom10070971.
Target Identification Using Homopharma and Network-Based Methods for Predicting Compounds Against Dengue Virus-Infected Cells.
Hengphasatporn K, Plaimas K, Suratanee A, Wongsriphisant P, Yang J, Shigeta Y
Molecules. 2020; 25(8).
PMID: 32325755
PMC: 7221756.
DOI: 10.3390/molecules25081883.
Assessing the Diversity and Stability of Cellular Immunity Generated in Response to the Candidate Live-Attenuated Dengue Virus Vaccine TAK-003.
Waickman A, Friberg H, Gargulak M, Kong A, Polhemus M, Endy T
Front Immunol. 2019; 10:1778.
PMID: 31417556
PMC: 6684763.
DOI: 10.3389/fimmu.2019.01778.
Dissecting the heterogeneity of DENV vaccine-elicited cellular immunity using single-cell RNA sequencing and metabolic profiling.
Waickman A, Victor K, Li T, Hatch K, Rutvisuttinunt W, Medin C
Nat Commun. 2019; 10(1):3666.
PMID: 31413301
PMC: 6694189.
DOI: 10.1038/s41467-019-11634-7.
Dengue Mosaic Vaccines Enhance Cellular Immunity and Expand the Breadth of Neutralizing Antibody Against All Four Serotypes of Dengue Viruses in Mice.
Hou J, Shrivastava S, Fraser C, Loo H, Wong L, Ho V
Front Immunol. 2019; 10:1429.
PMID: 31281322
PMC: 6596366.
DOI: 10.3389/fimmu.2019.01429.
B cell subset alteration and the expression of tissue homing molecules in dengue infected patients.
Pattanapanyasat K, Khowawisetsut L, Chuansumrit A, Chokephaibulkit K, Tangnararatchakit K, Apiwattanakul N
J Biomed Sci. 2018; 25(1):64.
PMID: 30149800
PMC: 6112127.
DOI: 10.1186/s12929-018-0467-8.
Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4.
Widman D, Young E, Nivarthi U, Swanstrom J, Royal S, Yount B
Sci Rep. 2017; 7(1):17169.
PMID: 29215033
PMC: 5719398.
DOI: 10.1038/s41598-017-17355-5.
Dissecting Antibodies Induced by a Chimeric Yellow Fever-Dengue, Live-Attenuated, Tetravalent Dengue Vaccine (CYD-TDV) in Naive and Dengue-Exposed Individuals.
Henein S, Swanstrom J, Byers A, Moser J, Shaik S, Bonaparte M
J Infect Dis. 2016; 215(3):351-358.
PMID: 27932620
PMC: 6392503.
DOI: 10.1093/infdis/jiw576.
Epidemiological trends of dengue disease in Mexico (2000-2011): a systematic literature search and analysis.
Dantes H, Farfan-Ale J, Sarti E
PLoS Negl Trop Dis. 2014; 8(11):e3158.
PMID: 25375162
PMC: 4222737.
DOI: 10.1371/journal.pntd.0003158.
Mouse models to study dengue virus immunology and pathogenesis.
Zellweger R, Shresta S
Front Immunol. 2014; 5:151.
PMID: 24782859
PMC: 3989707.
DOI: 10.3389/fimmu.2014.00151.
Role of humoral versus cellular responses induced by a protective dengue vaccine candidate.
Zellweger R, Miller R, Eddy W, White L, Johnston R, Shresta S
PLoS Pathog. 2013; 9(10):e1003723.
PMID: 24204271
PMC: 3814346.
DOI: 10.1371/journal.ppat.1003723.
Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase.
Byrd C, Grosenbach D, Berhanu A, Dai D, Jones K, Cardwell K
Antimicrob Agents Chemother. 2013; 57(4):1902-12.
PMID: 23403421
PMC: 3623359.
DOI: 10.1128/AAC.02251-12.
Variation in inflammatory/regulatory cytokines in secondary, tertiary, and quaternary challenges with dengue virus.
Sierra B, Perez A, Alvarez M, Garcia G, Vogt K, Aguirre E
Am J Trop Med Hyg. 2012; 87(3):538-47.
PMID: 22802438
PMC: 3435361.
DOI: 10.4269/ajtmh.2012.11-0531.
Controversies in dengue pathogenesis.
Halstead S
Paediatr Int Child Health. 2012; 32 Suppl 1:5-9.
PMID: 22668442
PMC: 3381449.
DOI: 10.1179/2046904712Z.00000000045.